-
Implementation Problem
-
Resolution: Unresolved
-
Moderate
-
None
-
Beaumont Health
-
-
Hospital Harm - Opioid Related Adverse Events
Naloxone administration is used as part of a sedation plan by an anesthesiologist in other areas outside of the operating room (ie, interventional radiology, endoscopy). These exclusions were not accounted for in your definitions.
Naloxone administration is used as part of a rapid response protocol when emergent reversal of a potential adverse event may be indicated, but was not the cause of the patient’s decline. We believe there should be a time limitation on how long prior to the naloxone use the opioid was administered. But this would be another calculation that the EMR cannot accommodate.
The numerator definition states to include patients who receive naloxone during the first 24 hrs of hospitalization with evidence of an opioid administration prior to the naloxone administration. Why would this be restricted to the first 24 hours only?
In general, currently our EMR does not accommodate the ability to generate QRDA files for us to create reports or dashboards to use for measure compliance and/or validation. It would take considerable resources to do so.